Medipharm Labs Corp (LABS) — Capital Reinvestment Ratio
Medipharm Labs Corp (LABS) has a Capital Reinvestment Ratio of 0.07x as of December 2023, meaning it reinvests 0% of its operating cash flow (CA$1.62 Million) in capital expenditures (CA$119.00K). See net asset quality index of Medipharm Labs Corp to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Medipharm Labs Corp Capital Reinvestment Ratio (2017–2017)
This chart tracks Medipharm Labs Corp's Capital Reinvestment Ratio across 1 annual periods. Check Medipharm Labs Corp cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Medipharm Labs Corp (2017–2017)
Year-by-year Capital Reinvestment Ratio for Medipharm Labs Corp from 2017 to 2017. For live market cap and broader valuation context, see LABS stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 12.92x | CA$166.00K | CA$2.14 Million | — |